Most Read Articles
Roshini Claire Anthony, 3 days ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 6 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
19 Jan 2020
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.

Haemodialysis not responsible for vitreous haemorrhage in diabetics

29 Oct 2019
The private sector’s support is needed to provide dialysis treatment for kidney patients.

Undergoing haemodialysis does not appear to increase the likelihood of vitreous haemorrhage in diabetes patients with proliferative diabetic retinopathy, a new study has shown.

Researchers performed a retrospective cohort study on 145 eyes of 102 patients on haemodialysis, and on 36 eyes of 21 patients on peritoneal dialysis. The incidence rates of vitreous haemorrhage 12 months before and after dialysis were compared between groups.

In the year after dialysis initiation, 34 eyes developed vitreous haemorrhage in the haemodialysis group, resulting in an overall incidence rate of 23.4 percent. This was not significantly different from that of the peritoneal dialysis group (n=8; 22.2 percent; p=1.00). The cumulative incidence of vitreous haemorrhage was likewise statistically similar between groups (p=0.941).

Moreover, severe vitreous haemorrhage requiring vitrectomy was reported in six eyes in the haemodialysis group and one in the peritoneal dialysis group. The incidence rates were comparable (17.6 percent vs 12.5 percent; p=1.00). In all the other cases, the vitreous haemorrhage resorbed spontaneously.

Longitudinal comparisons, however, showed that the incidence of vitreous haemorrhage was significantly reduced in the year during vs before haemodialysis (23.4 percent vs 35.2 percent; p=0.008).

Univariate analysis found that undergoing panretinal photocoagulation just before haemodialysis was a significant risk factor for vitreous haemorrhage development (p<0.001). Other variables, such as the duration of diabetes, blood pressure, medication and haemoglobin levels, had no significant effect.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 6 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
19 Jan 2020
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.